In a few weeks’ time, Germany will go to the polls to elect a new governing coalition, following the collapse of the center-left SPD’s “traffic light” coalition in November.
German Election 2025: Market Access And EU IVD Regulation In Focus For Medtechs Ahead Of Poll
Clinical Programs Risk Sliding Down Priority List And IVDR Is Impeding Care
Lawmaking in Germany came to a halt after the federal election was called, meaning cardiovascular detection and pharmacy legislation were put on hold. In part one of a two-part interview on key themes for industry, Martin Walger, chief executive of the IVDs industry association, the VDGH, lays out the hopes and fears of IVD companies in the run up to the late February vote.
More from Market Access
More from Market Intelligence
• By
Biotech BPGbio applies causal AI to generate insights from samples from what the CEO says is one of the world's largest biobanks. With several promising late-stage programs, its platform seems to be yielding fruit.
• By
Rentschler Biopharma CEO Benedikt von Braunmühl tells In Vivo about the CDMO's strategic decision to exit the cell and gene therapy manufacturing space.
• By
Twenty executives in the biopharma industry outline their expectations for key trends and developments this year. A selection of commentary from a broad industry survey by Scrip.